Cite

HARVARD Citation

    Gros, A. et al. (2015). Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online]. 
  
Back to record